CLOCK and acute lymphoblastic leukemia: Although our finding does support the potential use of Clock gene expression as a novel chronobiomarker in ALL, further studies would have to be performed on larger sample sizes as well as to look at the effect if any of chemotherapy on Clock gene expression to rule out the possibility of therapy intervention having a direct effect on the transcription of the Clock gene.